PHARMADEC
ActiveSummary
PHARMADEC has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.24M and a net result of €108k. Equity is growing by ~13.2% per year across the filed fiscal years. Its solvency ranks better than 95% of 9624 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability58▼-6
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100k at 30 days acceptable
Liquidity ample (current ratio 16.86 against 16.89 in 2023; short-term debt: 5.9% and cash: 77.7% of total assets), and 6.2% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
93.8%
Return on assets
8.2%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-06-2025, 51 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
51 d early
2023
29 d early
2022
30 d late
2021
53 d late
2020
29 d late
2019
9 d early
← before the deadline
after the deadline →
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Accepting this client? The AML file with identity, beneficial owners and sanctions lists.AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Financials · fiscal year 2024, abbreviated schema
Equity
€1.24M▲ 9.5%
2023 · €1.13M
Total assets
€1.32M▲ 9.8%
2023 · €1.20M
Net result
€108k▼ 13.8%
2023 · €125k
Working capital
€1.24M▲ 9.8%
2023 · €1.13M
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€133k▼ 15.1%€137k▲ 3.6%€153k▲ 11.5%€161k▲ 5.4%€145k▼ 10.0%
Net result€108k▼ 14.5%€111k▲ 2.9%€122k▲ 9.6%€125k▲ 2.5%€108k▼ 13.8%
Equity€773k▲ 16.3%€885k▲ 14.4%€1.01M▲ 13.8%€1.13M▲ 12.3%€1.24M▲ 9.5%
Total assets€923k▲ 15.4%€1.04M▲ 12.2%€1.17M▲ 13.5%€1.20M▲ 2.3%€1.32M▲ 9.8%
Debt€149k▲ 10.7%€151k▲ 0.9%€168k▲ 11.4%€71k▼ 57.6%€81k▲ 14.3%
Working capital€773k▲ 16.8%€885k▲ 14.5%€1.01M▲ 14.0%€1.13M▲ 12.0%€1.24M▲ 9.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 10% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €1.32M
Equity
€1.24M ▲ 9.5%
Debt
€81k ▲ 14.3%
Debt's share of the balance-sheet total rises from 5.9% to 6.2%. Equity and debt are higher.
Key figures and ratios
Current ratio
16.86▼
2023 · 16.89
Quick ratio
14.98▲
2023 · 14.83
Debt to equity
0.07▲
2023 · 0.06
ROE
8.7%▼
2023 · 11.1%
ROA
8.2%▼
2023 · 10.4%
Debt ≤ 1 year
€78k▲
2023 · €71k
Income taxes
€37k▼
2023 · €43k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3k | €691 | - | - | - | - |
| Other operating charges640/8 | - | €10k | €10k | €10k | €1k | ▼ 88.4% |
| Gross operating margin9900 | €145k | €148k | €163k | €171k | €146k | ▼ 14.5% |
| Operating profit (loss)9901 | €133k | €137k | €153k | €161k | €145k | ▼ 10.0% |
| Financial income75/76B | - | €11k | €11k | €12k | €3k | ▼ 77.4% |
| Recurring financial income75 | €11k | €11k | €11k | €12k | €3k | ▼ 77.4% |
| Financial charges65/66B | - | €6k | €6k | €6k | €3k | ▼ 42.7% |
| Recurring financial charges65 | €5k | €6k | €6k | €6k | €3k | ▼ 42.7% |
| Profit (loss) for the period before taxes9903 | €139k | €143k | €158k | €168k | €145k | ▼ 13.8% |
| Income taxes67/77 | €30k | €31k | €35k | €43k | €37k | ▼ 13.7% |
| Profit (loss) for the period9904 | €108k | €111k | €122k | €125k | €108k | ▼ 13.8% |
| Profit (loss) for the period to be appropriated9905 | €108k | €111k | €122k | €125k | €108k | ▼ 13.8% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €923k | €1.04M | €1.17M | €1.20M | €1.32M | ▲ 9.8% |
| Fixed assets21/28 | €691 | - | - | - | - | - |
| Tangible fixed assets22/27 | €691 | - | - | - | - | - |
| Current assets29/58 | €922k | €1.04M | €1.17M | €1.20M | €1.32M | ▲ 9.8% |
| Stocks and contracts in progress3 | €140k | €132k | €135k | €146k | €147k | ▲ 0.5% |
| Stocks30/36 | - | €132k | €135k | €146k | €147k | ▲ 0.5% |
| Amounts receivable within one year40/41 | €54k | €68k | €49k | €65k | €59k | ▼ 9.8% |
| Trade receivables40 | - | €66k | €48k | €65k | €55k | ▼ 15.3% |
| Other amounts receivable41 | - | €1k | €1k | €5 | €4k | ▲ 74,885% |
| Current investments50/53 | €78k | €78k | €78k | €78k | €78k | = |
| Cash at bank and in hand54/58 | €642k | €750k | €904k | €902k | €1.03M | ▲ 13.7% |
| Deferred charges and accrued income490/1 | - | €7k | €9k | €10k | €10k | ▲ 0.7% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €923k | €1.04M | €1.17M | €1.20M | €1.32M | ▲ 9.8% |
| Equity10/15 | €773k | €885k | €1.01M | €1.13M | €1.24M | ▲ 9.5% |
| Contributions10/11 | €62k | €62k | €62k | €62k | €62k | = |
| Capital10 | - | €62k | €62k | €62k | €62k | = |
| Issued capital100 | - | €62k | €62k | €62k | €62k | = |
| Reserves13 | €711k | €823k | €945k | €1.07M | €1.18M | ▲ 10.1% |
| Non-distributable reserves130/1 | - | €30k | €30k | €30k | €30k | = |
| Legal reserve130 | - | €30k | €30k | €30k | €30k | = |
| Distributable reserves133 | - | €792k | €915k | €1.04M | €1.15M | ▲ 10.4% |
| Profit (loss) carried forward14 | - | - | - | €0 | €0 | - |
| Amounts payable17/49 | €149k | €151k | €168k | €71k | €81k | ▲ 14.3% |
| Amounts payable within one year42/48 | €149k | €150k | €166k | €71k | €78k | ▲ 10.0% |
| Trade debts44 | €26k | €33k | €29k | €39k | €56k | ▲ 42.5% |
| Suppliers440/4 | - | €33k | €29k | €39k | €56k | ▲ 42.5% |
| Taxes, remuneration and social security45 | - | €7k | €14k | €10k | €9k | ▼ 10.1% |
| Taxes450/3 | - | €4k | €11k | €7k | €6k | ▼ 14.7% |
| Remuneration and social security454/9 | - | €3k | €3k | €3k | €3k | = |
| Other amounts payable47/48 | - | €110k | €123k | €22k | €14k | ▼ 38.4% |
| Accrued charges and deferred income492/3 | - | €383 | €2k | €0 | €3k | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €108k | €111k | €122k | €125k | €108k | ▼ 13.8% |
| + Depreciation and write-downs630 | €3k | €691 | - | - | - | - |
| Operating cash flow (approximation) | €111k | €112k | €122k | €125k | €108k | ▼ 13.8% |
| Change in cash | - | €109k | €154k | €-2k | €124k | ▲ 6,237% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
10-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
02-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Liquidity doublescurrent ratio 16.89
Current ratio from 7.08 to 16.89; short-term debt falls from €166k to €71k.
30-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 30 days late
2022
31-12
Financial
Equity above €1MEq €1.01M ▲13.8%
5 profitable years in a row build equity to €1.01M.
22-09
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 53 days late
2021
29-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 29 days late
2020
22-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Highest result since 2018net €127k ▲56.3%
Net result €127k, the highest in the series.
26-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 26 days late
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
30-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
29-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Westerlo · 1 establishment unit since 1990
Ground area
1,494 m²
Building footprint
309 m²
Volume, LiDAR
1,320 m³
Parcel 13049D1016/00D003, Flanders · tallest building 7.0 m, ±1 floor. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
APOTHEEK VERBANCK
since 19902.046.605.770
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13049D1016/00D003 | Flanders | 1,494 m² | 1 · 309 m² | 7.0 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Apotheek Kinget Bertem
BE 0861.501.342
Bertem · Eq €1,237,433
PHARMACIE COEUR DE VILLE
BE 0472.183.528
Ottignies-Louvain-la-Neuve · Eq €1,240,148
PHARMACIE TASQUIN
BE 0886.144.884
Dison · Eq €1,241,369
APOTHEEK DE GROOTE
BE 0439.249.058
Brakel · Eq €1,233,580
APOTHEEK BRUGSE POORT
BE 0885.568.131
Gent · Eq €1,233,405
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 2,847 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded27-12-1989
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Scores and ratios are computed by Checked and are not a credit decision.